We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

TECAN GROUP LTD.

Tecan is a provider of automated laboratory instruments and solutions for people working in clinical diagnostics, bas... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Two Chikungunya Virus IgM Enzyme-Linked Immunoassays Evaluated

By LabMedica International staff writers
Posted on 11 Feb 2020
Print article
Image: The Spark multimode reader performs accurate and sensitive measurements of fluorescent cell-based assays (Photo courtesy of TECAN).
Image: The Spark multimode reader performs accurate and sensitive measurements of fluorescent cell-based assays (Photo courtesy of TECAN).
Chikungunya virus (CHIKV) is an alphavirus transmitted by Aedes (Stegomyia) spp. mosquitoes. Transmission was initially restricted to small outbreaks and sporadic cases in Africa and Asia, but since early 2000s the virus has caused large outbreaks in India and Southeast Asia.

Acute clinical manifestations associated with CHIKV infections are non-specific, usually including fever, rash, and arthralgia, the latter being the most prominent symptom that may last for months or years, causing chronic disabilities. In areas where other arboviruses with similar clinical manifestations co-circulate laboratory diagnostic tools that distinguish CHIKV infections from them are urgently needed.

Scientists from the Fundação Oswaldo Cruz (Salvador, Brazil) enrolled 372 patients attending a public emergency health unit in an acute febrile illness (AFI) enhanced surveillance study and blood samples were drawn for arboviral diagnosis. All acute-phase sera, which had not been previously thawed, were submitted to RNA extraction and tested by reverse-transcription polymerase chain reaction (RT-PCR) for Dengue (DENV), Zika (ZIKV), and CHIKV.

The team tested the acute- and paired convalescent-phase sera available from all the CHIKV, DENV, and ZIKV RT-PCR-positive patients enrolled during surveillance with both the CHIKjj Detect IgM-capture ELISA kit (Inbios International, Inc., Seattle, WA, USA) and the Anti-Chikungunya virus ELISA (IgM) Test (Euroimmun, Luebeck, Germany). They also applied the Inbios and the Euroimmun CHIKV IgM ELISA tests to the acute- and paired convalescent-phase sera from 175 patients randomly selected from those with negative RT-PCR results (for all three arboviruses) and with paired sera available. The ELISA reading was performed by automated microplate reader at 450 nm (TECAN, Männedorf, Switzerland).

The scientists reported that the Inbios and Euroimmun tests’ sensitivities for acute samples were 4.0% and 10.3%, while for convalescent samples they were 92.4% and 96.9%, respectively. Overall, Inbios IgM ELISA specificities for acute and convalescent samples were 97.7% and 90.5%, respectively, and Euroimmun specificities were 88.5% and 83.9%, respectively.

The authors concluded that both tests presented high sensitivity for convalescent samples. However, the Euroimmun test returned more equivocal results and presented a slightly lower specificity, which might result in a higher rate of false positives if the test is used in scenarios of low CHIKV transmission, when the chance of CHIKV infection is lower. The study was published in the February, 2020 issue of International Journal of Infectious Diseases.


Related Links:
Fundação Oswaldo Cruz
Inbios International
Euroimmun
TECAN


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.